Molecular analysis of Fragile X syndrome

Current Protocols in Human Genetics

Volumn , Issue SUPPL.63, 2009, Pages

  Basehore, Monica J ^a   Friez, Michael J ^a  

^a GREENWOOD GENETIC CENTER   (United States)

Author keywords

Clinical; Diagnostic; Fragile X; Molecular; Testing

Indexed keywords

BUFFER; FRAGILE X MENTAL RETARDATION PROTEIN; GENOMIC DNA; OLIGONUCLEOTIDE; RESTRICTION ENDONUCLEASE; TRINUCLEOTIDE;

ACCURACY; ARTIFICIAL MEMBRANE; CHEMOLUMINESCENCE; DNA METHYLATION; FEMALE; FRAGILE X SYNDROME; GENE AMPLIFICATION; GENE MUTATION; HUMAN; MALE; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SOUTHERN BLOTTING; TRINUCLEOTIDE REPEAT;

BLOTTING, SOUTHERN; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MALE; POLYMERASE CHAIN REACTION; TRINUCLEOTIDE REPEATS;

EID: 75749133225     PISSN: 19348266     EISSN: 19348258     Source Type: Journal    
DOI: 10.1002/0471142905.hg0905s63     Document Type: Review

References (18)

1. Allingham-Hawkins, D.J., Babul-Hirji, R., Chitayat, D., Holden, J.J., Yang, K.T., Lee, C., Hudson, R., Gorwill, H., Nolin, S.L., Glicksman, A., Jenkins, E.C., Brown, W.T., Howard-Peebles, P.N., Becchi, C., Cummings, E., Fallon, L., Seitz, S., Black, S.H., Vianna-Morgante, A.M., Costa, S.S., Otto, P.A., Mingroni-Netto, R.C., Murray, A., Webb, J., MacSwinney, F., Dennis, N., Jacobs, P.A., Syrrou, M., Georgiou, I., Patsalis, P.C., Giovannucci Uzielli, M.L., Guarducci, S., Lapi, E., Cecconi, A., Ricci, U., Ricotti, G., Biondi, C., Scarselli, B., and Vieri, F. 1999. Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study- preliminary data. Am. J. Med. Genet. 83:322-325.
2. Brown, T. 1999. Southern blotting. Curr. Protoc. Mol. Biol. 68:2.9.1-2.9.20.
3. Brown, W.T., Houck, G.E. Jr., Jeziorowska, A., Levinson, F.N., Ding, X., Dobkin, C., Zhong, N., Henderson, J., Brooks, S., and Jenkins, E.C. 1993. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. J. Am. Med. Assoc. 270:1569-1575.
4. Crawford, D.C., Acuña, J.M., and Sherman, S.L. 2001. FMR1 and the fragile X syndrome: Human genome epidemiology review. Genet. Med. 3:359-371.
5. Cummins, J.H. 1997. The unique alteration of electrophoretic mobility of fragile-X-expanded fragments in the presence of ethidium bromide. Elsevier Trends Journals Technical Tips Online T01054, May 14, 1997.
6. Fu, Y.H., Kuhl, D.P.A., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, R., Verkerk, A., Holden, J.J.A., Fenwick, R.G. Jr., Warren, S.T., Oostra, B.A., Nelson, D.L., and Caskey, C.T. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67:1047-1058.
7. Hagerman, R.J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., Grigsby, J., Gage, B., and Hagerman, P.J. 2001. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127-130.
8. Houdayer, C., Lourdaux, J., Billette de Villemeur, T., Royer-Legrain, G., Bahuau, M., Bonnefont, J.P., Feldman, D., and Courderc, R. 2002. Simple fluorescent PCR assay for discriminating FRAXA fully mutated females from normal homozygotes. Genet. Test. 6:135-139.
9. Kramer, M.F. and Coen, D.M. 2001. Enzymatic amplification of DNA by PCR: Standard procedures and optimization. Curr. Protoc. Mol. Biol. 56:15.1.1-15.1.14.
10. Nolin, S.L., Lewis, F.A., Ye, L.L., Houck, G.E. Jr., Glicksman, A.E., Limprasert, P., Li, S.Y., Zhong, N., Ashley, A.E., Feingold, E., Sherman, S.L., and Brown, W.T. 1996. Familial transmission of the FMR1 CGG repeat. Am. J. Hum. Genet. 59:1252-1261.
11. Nolin, S.L., Brown, W.T., Glicksman, A., Houck, G.E. Jr., Gargano, A.D., Sullivan, A., Biancalana,V., Brondum-Nielsen, K.,Hjalgrim, H., Holinski-Feder, E., Kooy, F., Longshore, J., Macpherson, J., Mandel, J.L., von Koskull, H., and Sherman, S.L. 2003. Expansion of the fragileXCGGrepeat in femaleswith premutation or intermediate alleles. Am. J.Hum. Genet. 72:454-464.
12. Orrico, A., Galli, L., Plewnia, K., Dotti, M.T., Censini, S., and Federico, A. 1998. Mosaicism for full mutation and normal sized allele of the FMR1 gene: A new case report. Am. J. Med. Genet. 78:431-434.
13. Pergolizzi, R.G., Erster, S.H., Goonewardena, P., and Brown, W.T. 1992. Detection of full fragile X mutations by polymerase chain reaction. Lancet 339:271-272.
14. Perry-O'Keefe, H. and Kissinger, C.M. 1994. Chemiluminescent detection of nonisotopic probes. Curr. Protoc. Mol. Biol. 26:3.19.1-3.19.8.
15. Rousseau, F., Heitz, D., Biancalana, V., Blumenfeld, S., Kretz, C., Bou, J., Tommerup, N., Van Der Hagen, C., DeLozier-Blanchet, C., Croquette, M.-F., Gilgenkrantz, S., Jalbert, P., Voelckel, M.-A., Oberl, I., and Mandel, J.-L. 1991. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. New Engl. J. Med. 325:1673-1681.
16. Sherman, S., Pletcher, B.A., and Driscoll, D.A. 2005. Fragile X syndrome: Diagnostic and carrier testing. Genet. Med. 7:584-587.
17. Spector, E.B. and Kronquist, K.E. 2005. ACMG standards and guidelines for clinical genetics laboratories, 2005. Available at: http://www.acmg.net.
18. Verkerk, A.J.M.H., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P.A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F., Eussen, B.E., van Ommen, G.J.B., Blonden, L.A.J., Riggins, G.J., Chastain, J.L., Kunst, C.B., Galjaard, H., Caskey, C.T., Nelson, D.L., Oostra, B.A., andWarren, S.T. 1991. Identification of a gene (FMR1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.